States where Levity is currently available include: Colorado, Florida, Georgia, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Missouri, Montana, Nebraska, Nevada, New York, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Virginia, Washington, and Wyoming
COMP006 & COMP007 studies
Ipamorelin Peptide 2 mg
Retatrutide Peptide for Advanced Weight Loss and Metabolic Optimization Retatrutide is a next-generation triple agonist peptide that targets the GLP-1, GIP, and glucagon receptors
How Genetic Testing Personalizes Your GLP-1 Therapy PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to reveal how your body responds to GLP-1 medications at the genetic level
Changes in LDL cholesterol did not differ significantly among groups (p = 0.633